Genscript Biotech Corporation (GNNSF)
OTCMKTS · Delayed Price · Currency is USD
2.070
+0.400 (23.95%)
Jul 18, 2025, 4:00 PM EDT
Revenue by Product
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | NaN - NaN |
|---|---|---|---|---|---|---|
Life-science Services and Products | 3.52B | Log In | Log In | Log In | Log In | Upgrade |
Life-science Services and Products Growth | 11.03% | Log In | Log In | Log In | Log In | Upgrade |
Biologics Development Services | 684.87M | Log In | Log In | Log In | Log In | Upgrade |
Biologics Development Services Growth | -18.00% | Log In | Log In | Log In | Log In | Upgrade |
Industrial Synthetic Biology Products | 418.15M | Log In | Log In | Log In | Log In | Upgrade |
Industrial Synthetic Biology Products Growth | 24.52% | Log In | Log In | Log In | Log In | Upgrade |
Operation Unit | 19.44M | Log In | Log In | Log In | Log In | Upgrade |
Operation Unit Growth | 419.61% | Log In | Log In | Log In | Log In | Upgrade |
Cell Therapy | - | Log In | Log In | Log In | Log In | Upgrade |
Cell Therapy Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | NaN - NaN |
|---|---|---|---|---|---|---|
United States | 2.07B | Log In | Log In | Log In | Log In | Upgrade |
United States Growth | -47.78% | Log In | Log In | Log In | Log In | Upgrade |
China | 1.38B | Log In | Log In | Log In | Log In | Upgrade |
China Growth | 8.46% | Log In | Log In | Log In | Log In | Upgrade |
Europe | 631.49M | Log In | Log In | Log In | Log In | Upgrade |
Europe Growth | -18.95% | Log In | Log In | Log In | Log In | Upgrade |
Asia Pacific | 414.16M | Log In | Log In | Log In | Log In | Upgrade |
Asia Pacific Growth | -0.63% | Log In | Log In | Log In | Log In | Upgrade |
Other | 144.39M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 0.88% | Log In | Log In | Log In | Log In | Upgrade |